Plato Investment Management Ltd Cuts Stock Position in Abbott Laboratories $ABT

Plato Investment Management Ltd decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.2% during the 1st quarter, HoldingsChannel.com reports. The fund owned 42,648 shares of the healthcare product maker’s stock after selling 1,862 shares during the period. Plato Investment Management Ltd’s holdings in Abbott Laboratories were worth $5,719,000 as of [...]